Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension

Arthritis Care and Research

Volumn 49, Issue 1, 2003, Pages 85-92

  Ulanet, Danielle B ^a   Wigley, Fredrick M ^a   Gelber, Allan C ^a   Rosen, Antony ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibody; B23; Pulmonary hypertension; Scleroderma

Indexed keywords

AUTOANTIBODY; NUCLEOPHOSMIN; PHOSPHOPROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PULMONARY HYPERTENSION; SCLERODERMA;

EID: 0037440854     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10914     Document Type: Article

References (34)

1. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999;6:6-12.
2. Kahaleh B. Immunologic aspects of scleroderma. Curr Opin Rheumatol 1993;5:760-7.
3. Ochs RL, Lischwe MA, Spohn WH, Busch H. Fibrillarin: a new protein of the nucleolus identified by autoimmune sera. Biol Cell 1985;54:123-33.
4. Reimer G, Rose KM, Scheer U, Tan EM. Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest 1987;79:65-72.
5. Rodriguez-Sanchez JL, Gelpi C, Juarez C, Hardin JA. Anti-NOR 90: a new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. J Immunol 1987;139:2579-84.
6. Muller MT, Pfund WP, Mehta VB, Trask DK. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO J 1985;4:1237-43.
7. Ochs RL, Press RI. Centromere autoantigens are associated with the nucleolus. Exp Cell Res 1992;200:339-50.
8. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
9. Okano Y, Steen VD, Medsger TA, Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992;35:95-103.
10. Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA Jr. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 1996;23:639-42.
11. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis: anticentromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980;23:617-25.
12. Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984;27:125-31.
13. Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM, Tan EM. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 1992;140:859-70.
14. Lischwe MA, Smetana K, Olson MO, Busch H. Proteins C23 and B23 are the major nucleolar silver staining proteins. Life Sci 1979;25:701-8.
15. Savkur RS, Olson MO. Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease. Nucleic Acids Res 1998;26:4508-15.
16. Yung BY, Busch H, Chan PK. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim Biophys Acta 1985;826:167-73.
17. Schmidt-Zachmann MS, Hugle-Dorr B, Franke WW. A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J 1987;6:1881-90.
18. Feuerstein N, Chan PK, Mond JJ. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23: implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem 1988;263:10608-12.
19. Jiang PS, Yung BY. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis. Biochem Biophys Res Commun 1999;257:865-70.
20. Brankin B, Skaar TC, Brotzman M, Trock B, Clarke R. Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients. Cancer Epidemiol Biomarkers Prev 1998;7:1109-15.
21. Pfeifle J, Anderer FA, Franke M. Characterisation of nucleolar proteins as autoantigens using human autoimmune sera. Ann Rheum Dis 1986;45:978-86.
22. Kindas-Mugge I. Human autoantibodies against a nucleolar protein (published erratum appears in Biochem Biophys Res Commun 1990;31:980). Biochem Biophys Res Commun 1989; 163:1119-27.
23. Li XZ, McNeilage LJ, Whittingham S. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies. Arthritis Rheum 1989;32:1165-9.
24. Ritchie RF. Antinucleolar antibodies. Their frequency and diagnostic association. N Engl J Med 1970;282:1174-8.
25. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
26. Medsger Jr TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.
27. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
28. Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996;39:1151-60.
29. Lubben B, Rottmann N, Kubicka-Muranyi M, Gleichmann E, Luhrmann R. The specificity of disease-associated anti-fibrillarin autoantibodies compared with that of HgCl2-induced autoantibodies. Mol Biol Rep 1994;20:63-73.
30. Satoh M, Ajmani AK, Ogasawara T, Langdon JJ, Hirakata M, Wang J, et al. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome: specific recognition of the phosphorylated (IIO) form by a subset of human sera. J Clin Invest 1994;94:1981-9.
31. Neugebauer KM, Merrill JT, Wener MH, Lahita RG, Roth MB. SR proteins are autoantigens in patients with systemic lupus erythematosus: importance of phosphoepitopes. Arthritis Rheum 2000;43:1768-78.
32. Diot E, Giraudeau B, Diot P, Degenne D, Ritz L, Guilmot JL, et al. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 1999;116:715-20.
33. Imai H, Kiyosawa K, Chan EK, Tan EM. Autoantibodies in viral hepatitis-related hepatocellular carcinoma. Intervirology 1993;35:73-85.
34. Pinol-Roma S. Association of nonribosomal nucleolar proteins in ribonucleoprotein complexes during interphase and mitosis. Mol Biol Cell 1999;10:77-90.